Med Paper S.A. (CBSE:MDP)
Morocco · Delayed Price · Currency is MAD 25.55
0.00 (0.00%)
At close: Aug 11, 2026
Med Paper Income Statement
Financials in millions MAD. Fiscal year is January - December.
Millions MAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 88.41 | 105.56 | 107.86 | 134.73 | 78.99 | |
Revenue Growth | -16.25% | -2.13% | -19.94% | 70.56% | 35.16% |
Cost of Revenue | 59.9 | 57.86 | 54.09 | 80.13 | 46.71 |
Gross Profit | 28.51 | 47.7 | 53.77 | 54.6 | 32.29 |
Selling, General & Admin | 32.13 | 35.18 | 36.3 | 34.66 | 29.42 |
Other Operating Expenses | 6.74 | 6.32 | 6.6 | 6.16 | 5.4 |
Operating Expenses | 38.86 | 41.51 | 42.9 | 40.81 | 34.82 |
Operating Income | -10.36 | 6.2 | 10.87 | 13.79 | -2.54 |
Interest Expense | -4.64 | -3.3 | -4.68 | -5.06 | -1.44 |
Interest & Investment Income | - | - | 0.01 | - | - |
Earnings From Equity Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Currency Exchange Gain (Loss) | -0.03 | -0.01 | -0.08 | -0.06 | 0 |
Other Non Operating Income (Expenses) | -0.12 | 0.03 | 0.12 | -0.14 | -0 |
EBT Excluding Unusual Items | -15.14 | 2.92 | 6.24 | 8.53 | -3.97 |
Gain (Loss) on Sale of Assets | - | - | - | 0.09 | - |
Other Unusual Items | 22.13 | 5.34 | -0.22 | -0.65 | 13.92 |
Pretax Income | 6.99 | 8.26 | 6.02 | 7.97 | 9.95 |
Income Tax Expense | 0.28 | 0.28 | 0.27 | 0.54 | 0.46 |
Net Income | 6.71 | 7.99 | 5.75 | 7.43 | 9.48 |
Net Income to Common | 6.71 | 7.99 | 5.75 | 7.43 | 9.48 |
Net Income Growth | -15.93% | 38.85% | -22.59% | -21.67% | - |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 3 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 3 |
Shares Change | 1.24% | -1.41% | 0.18% | 85.24% | - |
EPS (Basic) | 1.40 | 1.69 | 1.20 | 1.55 | 3.67 |
EPS (Diluted) | 1.40 | 1.69 | 1.20 | 1.55 | 3.67 |
EPS Growth | -16.96% | 40.83% | -22.73% | -57.71% | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 12.51 | 12.13 | 8.25 | 4.94 | 14.12 |
Free Cash Flow Per Share | 2.62 | 2.57 | 1.72 | 1.03 | 5.47 |
Gross Margin | 32.25% | 45.19% | 49.85% | 40.52% | 40.88% |
Operating Margin | -11.71% | 5.87% | 10.08% | 10.23% | -3.21% |
Profit Margin | 7.59% | 7.56% | 5.33% | 5.51% | 12.01% |
Free Cash Flow Margin | 14.15% | 11.49% | 7.65% | 3.67% | 17.87% |
EBITDA | -4.84 | 7.33 | 16.28 | 18.7 | 1.66 |
EBITDA Margin | -5.47% | 6.95% | 15.10% | 13.88% | 2.11% |
D&A For EBITDA | 5.52 | 1.13 | 5.41 | 4.91 | 4.2 |
EBIT | -10.36 | 6.2 | 10.87 | 13.79 | -2.54 |
EBIT Margin | -11.71% | 5.87% | 10.08% | 10.23% | -3.21% |
Effective Tax Rate | 3.96% | 3.36% | 4.51% | 6.77% | 4.67% |
Revenue as Reported | 78.72 | 101.77 | 118.38 | 142.36 | 80.19 |